Simon Basseyn, M.D., has joined TCG Crossover as part of the $824 million firm’s investment team, which specializes in the life sciences.
Previously, Basseyn was a senior analyst at a life-sciences focused hedge fund based in New York called Ghost Tree Capital.
“I am thrilled to join the talented founding investment team at TCG X and eager to begin investing in companies developing innovative science across the crossover and public stages,” said Basseyn.
Chen Yu, founding managing partner at TCG X said that Basseyn’s strong technical background and diverse . . .
Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Annual subscriptions get you the most bang for your buck, including access to Alternatives Watch Research articles and out Annual Investor Compendium.
Monthly subscriptions and discounted corporate plans for up to 100 members also available.